Drug: Atorvastatin Injury: Rhabdomyolysis Quarter: 2016Q3
Total Records: 39 Number of Pages: 2
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
127042511 | ATORVASTATIN | Rhabdomyolysis | TEVA | 79.00 YR | M | 0 | 20160831 | SK |
127235921 | Atorvastatin | Rhabdomyolysis | RANBAXY | 68.00 YR | F | 0 | 20160908 | NO |
127240251 | ATORVASTATIN | Rhabdomyolysis | DR REDDYS | 70.00 YR | M | 0 | 20160908 | COUNTRY NOT SPECIFIED |
127240271 | ATORVASTATIN | Rhabdomyolysis | DR REDDYS | 66.00 YR | M | 0 | 20160908 | COUNTRY NOT SPECIFIED |
127287451 | ATORVASTATIN | Rhabdomyolysis | ASTRAZENECA | 79.00 YR | F | 0 | 20160909 | ES |
127365671 | ATORVASTATIN | Rhabdomyolysis | SANDOZ | 80.00 YR | M | 0 | 20160912 | ES |
127391031 | ATORVASTATIN | Rhabdomyolysis | MYLAN | 0.00 | 0 | 20160912 | ES | |
127528941 | Atorvastatin | Rhabdomyolysis | FDA-CTU | 47.00 YR | M | 106 KG | 20160915 | US |
127577871 | ATORVASTATIN | Rhabdomyolysis | FRESENIUS KABI | 77.00 YR | M | 0 | 20160919 | GB |
127606482 | ATORVASTATIN | Rhabdomyolysis | TEVA | 80.00 YR | M | 0 | 20160926 | ES |
127656221 | Atorvastatin | Rhabdomyolysis | DR REDDYS | 77.00 YR | M | 0 | 20160921 | GB |
127723531 | ATORVASTATIN | Rhabdomyolysis | MYLAN | 0.00 | 0 | 20160922 | GB | |
127728071 | ATORVASTATIN | Rhabdomyolysis | SANDOZ | 77.00 YR | M | 0 | 20160922 | GB |
127747521 | ATORVASTATIN | Rhabdomyolysis | MYLAN | 0.00 | 0 | 20160923 | TW | |
127772881 | ATORVASTATIN | Rhabdomyolysis | ACCORD | 77.00 YR | M | 0 | 20160924 | GB |
127781671 | ATORVASTATIN | Rhabdomyolysis | SANDOZ | 70.00 YR | F | 0 | 20160925 | TW |
127891961 | ATORVASTATIN | Rhabdomyolysis | TEVA | 77.00 YR | M | 0 | 20160928 | GB |
127909031 | Atorvastatin | Rhabdomyolysis | RANBAXY | 77.00 YR | M | 0 | 20160929 | GB |
127957521 | Atorvastatin | Rhabdomyolysis | INGENUS | 66.00 YR | F | 0 | 20160929 | US |
Total Records: 39 Number of Pages: 2